
PathoFinder is a privately owned nucleic acid diagnostics company founded in 2004 and located in the BioPartner Center in Maastricht.
The company focuses on the development and commercialization of a new generation of molecular diagnostics, with special emphasis on infectious disease. Our proprietary MultiFinderTM and SmartFinderTM technologies allows for the detection and differentiation of up to 25 viral and bacterial pathogens in a single assay.
PathoFinder has established collaborations with several leading clinical and academic centers across Europe and is selling products to several countries in the world.